REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sorbe Biotechnology (India) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sorbe Biotechnology (India) Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sorbe Biotechnology (india) Private Limited is an unlisted company, incorporated on 16/03/2001. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24239MH2001PTC131256 and registration number is 131256.

Legal Address
210-213, Dhanlaxmi Service Industrial Estate, Above Navneet Motors, Gokul Nagar, Thane (West),
Thane; Maharashtra; Postal Code: 400601

Contact Details: Purchase the Sorbe Biotechnology (India) Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sorbe Biotechnology (India) Private Limited report to view the information.
Outstanding Shares:
Purchase the Sorbe Biotechnology (India) Private Limited report to view the information.
Registered Capital:
Purchase the Sorbe Biotechnology (India) Private Limited report to view the information.
Incorporation Date:
March 16, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
99.96%
Subsidiaries
Auxilia Technologies Private Limited
51%
Company Performance
Financial values in the chart are available after Sorbe Biotechnology (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-26.13%▼
Total operating revenue
-26.89%▼
Operating profit (EBIT)
146.22%▲
EBITDA
27.4%▲
Net Profit (Loss) for the Period
137.37%▲
Total assets
-38.92%▼
Total equity
3.73%▲
Operating Profit Margin (ROS)
6.03%▲
Net Profit Margin
4.59%▲
Return on Equity (ROE)
7.39%▲
Debt to Equity Ratio
-68.31%▼
Quick Ratio
0.25%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo